(Q73816284)
Statements
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial (English)
Bogner JR
Roecken M
Herrmann DB
Boerner D
Kaufmann B
Gürtler L
Plewig G
scientific article published on 01 December 1997